Cytek Biosciences (CTKB) Asset Writedowns and Impairment (2020 - 2026)
Cytek Biosciences (CTKB) reported Asset Writedowns and Impairment of $193000.0 for Q1 2026, down 37.94% quarter-over-quarter from $311000.0 in Q4 2025.
Cytek Biosciences (CTKB) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Cytek Biosciences has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $193000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $193000.0; the trailing twelve-month figure through Mar 2026 stood at $606000.0 (up 162.09% YoY), and the FY2025 full-year result was $413000.0, up 745.31% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $193000.0, down from $311000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $912000.0 in Q1 2024, with the low at -$1.1 million in Q3 2024.
- Historically, Asset Writedowns and Impairment has averaged $104466.7 across 5 years, with a median of $125000.0 in 2024.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment sank 279.93% — and 2025, when it soared 3355.56%.
- Cytek Biosciences' Asset Writedowns and Impairment stood at $294000.0 in 2022, then slumped by 279.93% to -$529000.0 in 2023, then jumped by 101.7% to $9000.0 in 2024, then soared by 3355.56% to $311000.0 in 2025, then plunged by 37.94% to $193000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $193000.0 (Q1 2026), $311000.0 (Q4 2025), and $50000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Cytek Biosciences | - | - | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193,000.00 |
| Mar 31, 2026 | 193,000.00 |
| Dec 31, 2025 | 311,000.00 |
| Dec 31, 2025 | 311,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -1.11 Mn |
| Sep 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | 125,000.00 |
| Jun 30, 2024 | 125,000.00 |
| Mar 31, 2024 | 912,000.00 |
| Mar 31, 2024 | 912,000.00 |
| Dec 31, 2023 | -529,000.00 |
| Dec 31, 2023 | -529,000.00 |
| Sep 30, 2023 | 784,000.00 |
| Sep 30, 2023 | 784,000.00 |